Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin-based monotherapy from the market

An update on the latest status report on artemisinin resistance, providing an overview of WHO’s recommended regulatory actions and country progress to date to withdraw oral artemisinin-based monotherapy (oAMT) from the market.

← Back to previous page